Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

Unfortunately, these cells also often play a role in causing allergy and asthma symptoms. When everything is ... Subsequent ...

In North America, estimates range from 18% to 28%, with more than 4.7 million medical visits for GERD or reflux esophagitis taking ... is frequently comorbid with asthma, said Amy Eapen, MD ...

The incidence and prevalence of eosinophilic esophagitis in the United States are higher than previously reported, indicating increased disease burden, according to a poster presented here. EoE can ...

Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...

Medscape Emergency Medicine, October 04, 2022 S1 Episode 4: Team Effort: Multidisciplinary Approach to Severe Asthma Drs Wechsler ... of Refractory Eosinophilic Esophagitis Refractory eosinophilic ...

A Prescription Drug User Fee Act target date of December 16, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the Biologics License ...

The Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for depemokimab for asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps ...

The American College of Allergy, Asthma and Immunology (ACAAI) is a professional medical organization headquartered in Arlington Heights, Illinois, U.S.A., that promotes excellence in the practice ...

including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD) and other I&I indications, today provided pipeline progress ...